{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:12:45Z","timestamp":1790723565641,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jaad.2020.12.032","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T02:34:14Z","timestamp":1608863654000},"page":"1610-1618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis"],"prefix":"10.1016","volume":"84","author":[{"given":"Andi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Pachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2020.12.032_bib1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","article-title":"US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry","volume":"49","author":"Mendez","year":"2003","journal-title":"Arthritis Care Res"},{"issue":"8","key":"10.1016\/j.jaad.2020.12.032_bib2","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.3346\/jkms.2019.34.e55","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in Korea: a nationwide population-based study","volume":"34","author":"Cho","year":"2019","journal-title":"J Korean Med Sci"},{"issue":"8","key":"10.1016\/j.jaad.2020.12.032_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/34.8.732","article-title":"The incidence of juvenile dermatomyositis: results from a nation-wide study","volume":"34","author":"Symmons","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jaad.2020.12.032_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpeds.2017.12.053","article-title":"Advances in juvenile dermatomyositis: myositis specific antibodies aid in understanding disease heterogeneity","volume":"195","author":"Pachman","year":"2018","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jaad.2020.12.032_bib5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3476(83)80706-9","article-title":"Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification","volume":"103","author":"Bowyer","year":"1983","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.jaad.2020.12.032_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11926-014-0467-y","article-title":"The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis","volume":"16","author":"Hoeltzel","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"10.1016\/j.jaad.2020.12.032_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.berh.2017.12.003","article-title":"Juvenile dermatomyositis: latest advances","volume":"31","author":"Wu","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.12.032_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.10924","article-title":"Disease Activity Score for children with juvenile dermatomyositis: reliability and validity evidence","volume":"49","author":"Bode","year":"2003","journal-title":"Arthritis Care Res"},{"issue":"12","key":"10.1016\/j.jaad.2020.12.032_bib9","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/rheumatology\/keg403","article-title":"Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis","volume":"42","author":"Ruperto","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.jaad.2020.12.032_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13075-020-02164-5","article-title":"Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients","volume":"22","author":"Campanilho-Marques","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"0 11","key":"10.1016\/j.jaad.2020.12.032_bib11","first-page":"S118","volume":"63 suppl 11","author":"Rider","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.jaad.2020.12.032_bib12","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/acr.21637","article-title":"Quality of life in adults with juvenile-onset dermatomyositis: a case-control study","volume":"64","author":"Tollisen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10019","key":"10.1016\/j.jaad.2020.12.032_bib13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","article-title":"Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial","volume":"387","author":"Ruperto","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jaad.2020.12.032_bib14","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1136\/annrheumdis-2013-203279","article-title":"In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity","volume":"73","author":"Schwartz","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.jaad.2020.12.032_bib15","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/acr.22867","article-title":"Comparison of the utility and validity of three scoring tools to measure skin involvement in patients with juvenile dermatomyositis","volume":"68","author":"Campanilho-Marques","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.jaad.2020.12.032_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1759720X11424460","article-title":"Juvenile dermatomyositis: new insights and new treatment strategies","volume":"4","author":"Martin","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"10.1016\/j.jaad.2020.12.032_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/art.23299","article-title":"Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis","volume":"58","author":"Christen-Zaech","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.jaad.2020.12.032_bib18","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1002\/art.23960","article-title":"Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features","volume":"58","author":"Stringer","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jaad.2020.12.032_bib19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00002281-200211000-00005","article-title":"Clinical outcomes in juvenile dermatomyositis","volume":"14","author":"Ramanan","year":"2002","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"10.1016\/j.jaad.2020.12.032_bib20","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)\u2014clinical characteristics of children recruited within the first 5\u2009yr","volume":"45","author":"McCann","year":"2006","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.jaad.2020.12.032_bib21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/acr.22142","article-title":"Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry","volume":"66","author":"Robinson","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.jaad.2020.12.032_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2214\/ajr.142.2.397","article-title":"Patterns of calcification in childhood dermatomyositis","volume":"142","author":"Blane","year":"1984","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.jaad.2020.12.032_bib23","first-page":"782","article-title":"Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients","volume":"28","author":"Mathiesen","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.12.032_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.jaad.2020.12.032_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.122196","article-title":"Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis","volume":"47","author":"Fisler","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.12.032_bib26","first-page":"379","article-title":"Juvenile dermatomyositis: the association of the TNFa-308A allele and disease chronicity","volume":"5","author":"Pachman","year":"2001","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.12.032_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"7","key":"10.1016\/j.jaad.2020.12.032_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jaad.2020.12.032_bib29","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.12.032_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/annrheumdis-2017-212141","article-title":"Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research","volume":"77","author":"McCann","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jaad.2020.12.032_bib31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-857X(05)70350-1","article-title":"Classification and treatment of the juvenile idiopathic inflammatory myopathies","volume":"23","author":"Rider","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"issue":"10","key":"10.1016\/j.jaad.2020.12.032_bib32","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","article-title":"TNF\u03b1-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor \u03b1, disease duration, and pathologic calcifications","volume":"43","author":"Pachman","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jaad.2020.12.032_bib33","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.40060","volume":"69","author":"Rider","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.jaad.2020.12.032_bib34","first-page":"1995","article-title":"Intravenous corticosteroids: adverse reactions are more variable than expected in children","volume":"25","author":"Klein-Gitelman","year":"1998","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.12.032_bib35","article-title":"Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy prevents calcinosis and shortens disease course in juvenile dermatomyositis (JDMS)","volume":"37","author":"Callen","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.jaad.2020.12.032_bib36","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/art.27529","article-title":"Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells","volume":"62","author":"Shrestha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.jaad.2020.12.032_bib37","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.3899\/jrheum.100537","article-title":"Benign pneumatosis intestinalis in a patient with juvenile dermatomyositis","volume":"37","author":"Berard","year":"2010","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2020.12.032_bib38","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jpeds.2011.05.015","article-title":"Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis","volume":"159","author":"Eimer","year":"2011","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jaad.2020.12.032_bib39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.23341","article-title":"Pharmacokinetic study of oral prednisolone compared with intravenousmethylprednisolone in patients with vasculitis of rheumatic disease","volume":"59","author":"Rouster-Stevens","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"suppl 10","key":"10.1016\/j.jaad.2020.12.032_bib40","first-page":"1326","article-title":"Cutaneous gene expression signatures in juvenile myositis reveal a prominent IFN signature in lesional skin [abstract]","volume":"71","author":"Turnier","year":"2019","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.jaad.2020.12.032_bib41","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1002\/art.34659","article-title":"Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course","volume":"64","author":"Reed","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jaad.2020.12.032_bib42","first-page":"1198","article-title":"Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children","volume":"25","author":"Pachman","year":"1998","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.12.032_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpeds.2005.10.032","article-title":"Duration of illness is an important variable for untreated children with juvenile dermatomyositis","volume":"148","author":"Pachman","year":"2006","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jaad.2020.12.032_bib44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/acr.20071","article-title":"Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference","volume":"62","author":"Huber","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.jaad.2020.12.032_bib45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3899\/jrheum.190494","article-title":"Pilot study of the juvenile dermatomyositis consensus treatment plans: a CARRA Registry study","volume":"48","author":"Liu","year":"2020","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.12.032_bib46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3899\/jrheum.160688","article-title":"Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with persistent skin rash","volume":"44","author":"Huber","year":"2016","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.12.032_bib47","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/art.24571","article-title":"Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment","volume":"60","author":"Kim","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jaad.2020.12.032_bib48","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/art.27379","article-title":"Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis","volume":"62","author":"Ostrowski","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jaad.2020.12.032_bib49","first-page":"1644","article-title":"Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops","volume":"31","author":"Smith","year":"2004","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.12.032_bib50","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/01.bor.0000434664.37880.ac","article-title":"The diagnostic utility of autoantibodies in adult and juvenile myositis","volume":"25","author":"Tansley","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.12.032_bib51","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","article-title":"Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis","volume":"43","author":"Huber","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.12.032_bib52","doi-asserted-by":"crossref","DOI":"10.1186\/s41927-020-00150-7","article-title":"Novel serum protein biomarkers for juvenile dermatomyositis: a pilot study","author":"Tawalbeh","year":"2020","journal-title":"BMC Rheumatol"},{"issue":"7","key":"10.1016\/j.jaad.2020.12.032_bib53","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/art.41236","article-title":"Endothelial and inflammation biomarker profiles at diagnosis reflecting clinical heterogeneity and serving as a prognostic tool for treatment response in two independent cohorts of patients with juvenile dermatomyositis","volume":"72","author":"Wienke","year":"2020","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.12.032_bib54","first-page":"1986","article-title":"Eye findings in patients with juvenile dermatomyositis","volume":"32","author":"Akikusa","year":"2005","journal-title":"J Rheumatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220332230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220332230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:59:15Z","timestamp":1759273155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220332230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0190962220332230"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.12.032","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.12.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}